Should Hospitalized Patients Keep Their CGMs and Insulin Pumps? The 2026 Standards Say Yes

For years, hospital admission often meant disconnecting patients from their personal diabetes devices. Continuous glucose monitors (CGMs) and insulin pumps were frequently removed, even when patients had used them successfully at home. However, the 2026 American Diabetes Association (ADA) Standards of Care introduce a significant shift in how hospitals approach inpatient diabetes technology protocols.

The updated guidance encourages health systems to develop formal hospital diabetes technology policies that allow eligible patients to continue using their personal devices during hospitalization. This change reflects the growing role of diabetes technology in everyday care. It also recognizes that many patients understand their devices better than anyone else in the room.

Table of Contents

• Why the ADA Updated Hospital Diabetes Technology Guidance
• Building Effective Hospital Diabetes Technology Policies
• Staff Training and Safety Considerations
• CGMs, Insulin Pumps, and Inpatient Diabetes Care
• Conclusion
• FAQs

Why the ADA Updated Hospital Diabetes Technology Guidance

The use of CGMs and insulin pumps has become standard practice for many people living with diabetes. Consequently, many patients arrive at the hospital already relying on these tools to guide daily insulin decisions. In the past, hospitals often discontinued personal devices because of concerns about accuracy, staff familiarity, and liability.

However, switching a patient from a familiar diabetes system to a temporary hospital regimen can create confusion. It may also disrupt glucose patterns that were previously stable. Therefore, the 2026 ADA Standards encourage hospitals to evaluate whether patients can safely continue using their devices during admission.

This does not mean every patient should keep using a CGM or insulin pump in the hospital. Instead, it means hospitals need clear criteria. Patients should be alert, capable of self-management, and able to communicate with the care team. In addition, clinicians need a plan for verifying glucose values and documenting device use.

Building Effective Hospital Diabetes Technology Policies

Developing clear policies for inpatient diabetes technology begins with patient selection. Not every hospitalized person will qualify. For example, patients with altered mental status, critical illness, or rapidly changing insulin needs may need hospital-managed insulin therapy instead.

Documentation is also essential. Upon admission, clinicians should record the device type, current settings, insulin delivery parameters, sensor location, infusion site location, and patient responsibilities. Additionally, the medical record should include backup plans in case the device fails or must be removed.

Point-of-care glucose testing remains important, even when a patient uses a CGM. Although CGMs provide helpful trend data, hospitals should confirm readings with approved bedside testing when making treatment decisions. This extra step helps protect patient safety while supporting continued use of personal diabetes devices.

Clear communication also matters. Nurses, hospitalists, endocrinologists, pharmacists, and diabetes educators should understand their roles. As a result, many hospitals may benefit from standardized order sets, consent forms, and electronic health record templates.

Staff Training and Safety Considerations

Even strong policies can fail without staff education. Many clinicians have limited experience with insulin pumps, CGMs, and automated insulin delivery systems. Therefore, hospitals should provide practical training that explains device basics, alarm management, troubleshooting, and escalation procedures.

Staff also need to know when personal device use should stop. For example, a patient going into surgery may need a temporary transition plan. Similarly, a patient who becomes confused, unstable, or unable to manage the device may no longer be a safe candidate.

Hospitals should also prepare for common device problems. Sensors can loosen, infusion sets can fail, batteries can run low, and smartphones can lose connectivity. Consequently, backup insulin orders should always be available.

These safety steps are not barriers to patient-centered care. Instead, they make continued diabetes technology use safer and more consistent. With the right training, hospitals can support patient autonomy while maintaining clinical oversight.

CGMs, Insulin Pumps, and Inpatient Diabetes Care

Allowing eligible patients to continue CGMs and insulin pumps during hospitalization offers several benefits. First, patients often feel more confident using technology they already know. This comfort can reduce anxiety during an already stressful hospital stay.

Second, continued use may support more stable glucose management. Patients who rely on insulin pumps or automated insulin delivery systems may have patterns that are difficult to replicate with short-term hospital regimens. Therefore, keeping the same system in place may help avoid unnecessary glucose swings.

Patient satisfaction is another important factor. Many people with diabetes invest significant time learning how to use their devices effectively. Asking them to abandon that technology without a clear reason can feel frustrating and unnecessary.

Nevertheless, hospitals must balance autonomy with safety. The goal is not unrestricted device use. Rather, the goal is structured, evidence-based management through well-designed hospital diabetes technology guidelines.

Conclusion

The 2026 ADA Standards of Care mark an important change in inpatient diabetes management. Rather than routinely discontinuing personal CGMs and insulin pumps, hospitals are encouraged to establish formal policies that support continued use of diabetes technology for appropriate patients.

Successful inpatient diabetes technology protocols require clear documentation, point-of-care verification, staff training, patient selection criteria, and backup plans. When these elements are in place, hospitals can protect patient safety while respecting the experience and confidence many patients bring to their own diabetes care.

FAQs

Can hospitalized patients keep their insulin pumps during admission?

Yes. Eligible patients may be able to continue using insulin pumps if the hospital has appropriate policies and safety procedures in place.

Do hospitals still need fingerstick glucose checks if a patient uses a CGM?

Yes. Point-of-care glucose testing is usually needed to verify CGM readings before treatment decisions are made.

Who qualifies to keep using diabetes technology in the hospital?

Patients generally need to be alert, medically stable, able to manage the device, and able to communicate with the care team.

Why do hospitals need formal diabetes technology policies?

Formal policies help standardize documentation, safety checks, staff responsibilities, and backup plans for hospitalized patients using personal devices.

What are the benefits of continuing CGMs and insulin pumps in the hospital?

Potential benefits include better continuity of care, improved patient confidence, fewer disruptions to established routines, and more personalized glucose management.

Disclaimer: This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.